The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Related Party Transaction

24 Jul 2015 15:12

RNS Number : 0682U
Maven Income and Growth VCT 5 PLC
24 July 2015
 



Maven Income and Growth VCT 5 PLC (the "Company")

 

Statement re Related Party Transaction

 

The Company is managed by Maven Capital Partners UK LLP ("Maven").

 

The Company has agreed with Maven that the base fee rate of the annual management fee payable to Maven under the investment management agreement will increase from 1.5% to 1.6% of total assets of the Company (exclusive of VAT) with effect from 1 June 2015. This increase in the base fee has been agreed by the Company in order to compensate Maven for additional fixed costs that it has committed to pay on behalf of the Company. As Maven is a related party of the Company under the Listing Rules, the increase in the fee payable by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Pursuant to an offer agreement dated 20 October 2014 between the Company and Maven in relation to an offer for subscription launched by the Company pursuant to a joint prospectus dated 20 October 2014, the Company agreed to the payment to Maven of a fee of an amount equal to 2.5% of the amounts remitted to the Company with an investor's application (including any amounts requested to be facilitated) in respect of applications accepted under that offer less (i) an amount equal to any early investment incentive discounts being made available by the Company (as set out in the prospectus) in respect of applications accepted under that offer, and (ii) any amounts that Maven agreed to waive in respect of applications accepted under that offer. As Maven was a related party of the Company under the Listing Rules at the time, the payment of such fee by the Company to Maven was a transaction to which Listing Rule 11.1.10R applied.

Further, William Nixon and his spouse agreed, in relation to the offer referred to above and prior to the close of that offer, to subscribe for up to £60,000 of shares in the Company. As associates of Maven, William Nixon and his spouse were related parties of the Company under the Listing Rules and consequently the subscriptions were transactions to which Listing Rule 11.1.10R applied.

The fees paid to Maven under the offer agreement and the subscriptions for shares of William Nixon and his spouse in the Company (as referred to above) have been taken into account in determining the application of the related party rules of the Listing Rules to the increase in the base fee rate of the annual management fee referred to above.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRZZLFLEDFFBBB
Date   Source Headline
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.